Bryostatin-1 Effect on HIV-1 Latency and Reservoir in HIV-1 Infected Patients Receiving Antiretroviral Treatment
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
Phase I, randomized, double blind, placebo-controlled, dose-finding trial. The trial´s goal
is to evaluate two different doses of Bryostatin on HIV-1 latency and reservoir in HIV-1
infected patients receiving antiretroviral treatment.
Phase:
Phase 1
Details
Lead Sponsor:
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal